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When dietary carbohydrate is unavailable,
glucose required to support metabolism in vital
tissues is generated via gluconeogenesis in the
liver. Expression of phosphoenolpyruvate car-
boxykinase (PEPCK), commonly considered
the control point for liver gluconeogenesis, is
normally regulated by circulating hormones to
match systemic glucose demand. However,
this regulation fails in diabetes. Because other
molecular and metabolic factors can also influ-
ence gluconeogenesis, the explicit role of
PEPCK protein content in the control of gluco-
neogenesis was unclear. In this study, meta-
bolic control of liver gluconeogenesis was
quantified in groups of mice with varying
PEPCK protein content. Surprisingly, livers
with a 90% reduction in PEPCK content showed
only a 40% reduction in gluconeogenic flux,
indicating a lower than expected capacity for
PEPCK protein content to control gluconeo-
genesis. However, PEPCK flux correlated
tightly with TCA cycle activity, suggesting that
under some conditions in mice, PEPCK expres-
sion must coordinate with hepatic energy me-
tabolism to control gluconeogenesis.
INTRODUCTION
Gluconeogenesis from lactate and amino acids is impor-
tant for the maintenance of circulating glucose levels dur-
ing fasting (Chandramouli et al., 1997) or strenuous activity
(Petersen et al., 2004). This process occurs predominantly
in liver under normal conditions and ensures a continuous
supply of glucose for red blood cells and the central ner-
vous tissues, systems that are incapable of metabolizing
fatty acids. Normally, gluconeogenesis is under exquisitecontrol to ensure that rates of glucose production pre-
cisely match whole-body glucose requirements, but this
regulation appears to fail in diabetes (Boden et al., 2001;
Wajngot et al., 2001). For this reason, the mechanisms
by which gluconeogenesis is controlled have been widely
studied, yet they remain incompletely understood.
Gluconeogenesis can be considered the reversal of gly-
colysis (Pilkis and Granner, 1992), with the exception of
a few specific steps in which unique enzymes are used
either to bypass a thermodynamically unfavorable step or
to avoid uncontrolled futile cycling (Pilkis and Granner,
1992). For example, the last step in glycolysis is the con-
version of phosphoenolpyruvate (PEP) to pyruvate, a ther-
modynamically favorable reaction catalyzed by pyruvate
kinase (PK). Under typical cellular conditions, the liver
PK reaction is irreversible, so an alternate pathway for
converting pyruvate back into PEP is required for contin-
ual glucose production. This is accomplished in two enzy-
matic steps: conversion of pyruvate to oxaloacetate (OAA)
catalyzed by pyruvate carboxylase (PC), followed by con-
version of OAA to PEP catalyzed by phosphoenolpyruvate
carboxykinase (PEPCK) (Hanson and Garber, 1972). The
latter step is commonly considered rate controlling in
gluconeogenesis (Rognstad, 1979).
The concept that PEPCK expression is rate controlling
for gluconeogenesis has prompted numerous investiga-
tions of themechanisms that control PEPCK gene expres-
sion, as previously reviewed (Chakravarty et al., 2005;
Granner and Pilkis, 1990; Hanson and Reshef, 1997).
These studies have revealed that the PEPCK promoter
has binding sites for transcription factors directly related
to glucose homeostasis. For example, CREB (Leahy
et al., 1999), C/EBPa (Roesler et al., 1989), and Foxo1
(Schmoll et al., 2000; Zhang et al., 2006) are important in
the induction of hepatic PEPCK expression in response
to fasting or stress and its attenuation during feeding as
reflected by changes in circulating levels of insulin, gluca-
gon, and glucocorticoids. Accordingly, PEPCK is overex-
pressed in all forms of diabetes, in which gluconeogenesis
is inappropriately high (Veneziale et al., 1983), and a 7-fold
overexpression of PEPCK inmice results in hyperglycemiaCell Metabolism 5, 313–320, April 2007 ª2007 Elsevier Inc. 313
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coordinated and appears to parallel whole-body glucose
demand, PEPCK expression is widely used as an indicator
of changes in gluconeogenic flux in response to molecular
or pharmacologic interventions (Chakravarty et al., 2005).
Although robust control of PEPCK gene expression is
consistent with the concept that PEPCK is rate controlling
for gluconeogenesis, metabolic control theory suggests
that regulation of such a critical pathway by a single en-
zyme is unlikely (Fell, 1997), and metabolic control analy-
sis of gluconeogenesis in hepatocytes provides evidence
to the contrary (Argaud et al., 1991; Groen et al., 1986;
Rigoulet et al., 1987). Adaptive regulation of other en-
zymes in the gluconeogenic pathway, by either gene ex-
pression or allosteric modification of activity, also high-
lights the importance of the entire network in regulation
of gluconeogenic flux, but it does not explicitly exclude
a dominant role for PEPCK. Recently, a number of mouse
models have been generated with impaired PEPCK gene
expression, allowing a detailed study of the role of PEPCK
protein content in gluconeogenesis (She et al., 2000).
Surprisingly, changes in PEPCK expression fail to dramat-
ically impact fasting glycemia, while, for instance, alter-
ation in the activity of glucokinase, a rate-limiting enzyme
for glycolysis, has profound effects (Magnuson et al.,
2003). Data from these mouse models suggest that liver
PEPCK plays a role more complex than simply regulating
gluconeogenesis. Disruption of hepatic energy metabo-
lism in these mice (Burgess et al., 2004; She et al., 2000)
and in an independent mouse model lacking cytosolic
PEPCK (Hakimi et al., 2005) suggests that PEPCK flux
may interact with energy generation in the hepatic TCA cy-
cle. In addition, Hanson and coworkers (Chakravarty et al.,
2005) identified PEPCK as a critical enzyme for the synthe-
sis of glycerol-3-phosphate, used in esterification of fatty
acids to triglycerides. These new data prompted us to
examine the capacity of PEPCK protein content to control
hepatic gluconeogenesis and to determine whether al-
tered PEPCK flux correlates with changes in hepatic en-
ergy production in intact livers from mice with graded
PEPCK protein content. PEPCK protein content was
found to weakly influence flux through the pathway, while
hepatic energy production strongly correlated with the
rate of gluconeogenesis.
RESULTS
Postperfusion assay of PEPCK protein content revealed
that livers from pckdel/W, pcklox/neo, and pcklox + neo/del
mice had 80%, 30%, and 10% PEPCK protein levels (re-
spectively) compared to control pcklox/lox mice, and
pcklox/lox + AlbCremice had undetectable levels of PEPCK
protein compared to the control mice (Figure 1A). Meta-
bolic fluxes through gluconeogenesis, PEPCK, pyruvate
cycling, and TCA cycle oxidation were measured using
2H2O and [U-
13C3]propionate tracers. These measure-
ments are based on the fact that glucose cannot become
2H enriched in position H6s or labeled with 13C in any po-
sition without PEPCK activity (Figure 1B) (Burgess et al.,314 Cell Metabolism 5, 313–320, April 2007 ª2007 Elsevier In2004). NMR was used to detect the appearance of these
tracers in glucose, and, as anticipated, glucose produced
by livers lacking cytosolic PEPCK had extremely low deu-
terium enrichment in the H6s position and close to natural-
abundance 13C in all carbon resonances (Figure 1C, top),
as previously reported (Burgess et al., 2004). In contrast,
livers with as little as 10% of normal PEPCK protein con-
tent produced glucose with substantial 2H and 13C label-
ing in the H6s and C2 positions, respectively, consistent
with gluconeogenesis from substrates passing through
the TCA cycle (Figure 1C).
There were no significant differences in the percent of
glucose synthesized from PEP in livers with 80% or even
30% PEPCK protein content compared to controls (Table
1). Livers with 10% PEPCK content had 15% less glu-
cose coming from PEP and a corresponding increase in
glucose coming from glycerol. 13C NMR of liver effluent
glucose reported a decline in the relative fluxes through
PEPCK, pyruvate cycling, and gluconeogenesis (relative
to TCA cycle flux) only in livers with 30% or less of normal
PEPCK content (Table 1). Total glucose production drop-
ped by 25% when PEPCK content was 10% of control
and remained at 43% in livers completely lacking
PEPCK. This indicates that even PEPCK null livers retain
an ability to synthesize glucose from source besides
PEP; 2H NMR showed clearly that virtually all of the re-
maining glucose production was accounted for by gluco-
neogenesis from glycerol. Oxygen consumption was rela-
tively insensitive to changes in PEPCK content, except in
the null liver, which showed a 20% decrease (Table 2).
Absolute fluxes through multiple pathways contributing
to glucose production were evaluated by combining NMR
data with measured glucose production (Burgess et al.,
2004, 2006; Hausler et al., 2006). This analysis showed
that in livers with PEPCK content reduced to 30% and
10% of normal, PEPCK flux was reduced by 25% and
40%, respectively (Figure 2A). A metabolic control analy-
sis (Fell, 1997) of these data indicated that in the intact
isolatedmouse liver, PEPCK has ametabolic control coef-
ficient of 0.18 for gluconeogenesis from the level of the
TCA cycle. According to metabolic control theory, a
rate-controlling enzyme should have a control coefficient
approaching 1, while an enzyme with no influence on
flux through a pathway will have a control coefficient ap-
proaching 0 (Fell, 1997). These results indicate that liver
PEPCK protein content has limited control over gluconeo-
genesis from the TCA cycle in the isolated perfused liver;
a result that is inconsistent with the standard textbook
teaching that gluconeogenesis is regulated by PEPCK
expression.
Interestingly, TCA cycle flux determined fromNMR data
(Table 2) is linearly proportional to PEPCK flux,with a slope
near 1 (Figure 2B). This observation suggests that as glu-
coneogenesis doubles, oxidative flux through the TCA cy-
clemust also approximately double. Oxygen consumption
also correlated with glucose production in these livers, but
a doubling of glucose production required only a 30% in-
crease in O2 consumption (Table 2). This is likely because
the majority of fasting hepatic energy consumptionc.
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NMR Analysis of PEPCK Control StrengthFigure 1. Effect of PEPCK Protein Content on 2H and 13C Tracer Incorporation into Glucose
(A) Western blots for PEPCK and tubulin protein content. Relative PEPCK content was determined from the PEPCK/tubulin ratio normalized to 100%
for the control strain (pcklox/lox). Mean ± SEM is reported.
(B) The carbons used for gluconeogenesis originate in the TCA cycle. Glucose cannot become 2H enriched at position H6s or labeled with 13C in any
position without PEPCK activity. NMR can be used to measure these enrichments and combined with total glucose production to determine flux
through the TCA cycle and gluconeogenesis.
(C) Decreasing the PEPCK protein content inmice causes only small changes in the 2H enrichment of H6s (left box) or the C2 13Cmultiplets (right box).
This indicates significant rates of gluconeogenesis despite low levels of PEPCK protein content. Only glucose from the PEPCK null livers had dra-
matically reduced 2H or 13C enrichment in these positions, indicating that those livers produced glucose from glycerol rather than the TCA cycle (Bur-
gess et al., 2004). 13Cmultiplets are labeled Q (quartet), D12 (doublet 12), D34 (doublet 34), and S (singlet). The areas of these multiplets represent the
isotopomer distribution of 13C in glucose and are used to determine fluxes associated with the TCA cycle (Jones et al., 1997).(as reflected by O2 uptake) is provided by b-oxidation and
ketogenesis (especially in the presence of octanoate)
rather than terminal oxidation in the TCA cycle (McGarry
and Foster, 1980). Nonetheless, the responsiveness of
the TCA cycle to gluconeogenesis suggests that energy
generated in the hepatic TCA cycle during fasting is
closely associated with the rate of gluconeogenesis.CDISCUSSION
Early experiments on isolated hepatocytes treated with
pharmacological inhibitors of PEPCK activity yielded con-
flicting results concerning the role of PEPCK in control of
gluconeogenesis. Rognstad (1979) concluded that PEPCK
is the rate-controlling enzyme for gluconeogenesis basedell Metabolism 5, 313–320, April 2007 ª2007 Elsevier Inc. 315
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NMR Analysis of PEPCK Control StrengthTable 1. Protein Content from Western Blotting and Relative Fluxes from NMR Analysis in Isolated Perfused Livers
Strain pcklox/lox pckdel/W pcklox/neo pcklox + neo/del pcklox/lox + AlbCre
PEPCK protein content 100% ± 10% 81% ± 7%# 31% ± 2%# 10% ± 3%# 0% (bd)#
Data from 2H NMR: sources of effluent glucose (%)
Glycogen 6 ± 5 0 ± 2 9 ± 9 0 ± 3 5 ± 6*
Glycerol 48 ± 15 52 ± 5 35 ± 5 60 ± 5 88 ± 7*
PEP 46 ± 11 48 ± 4 56 ± 5 40 ± 4 7 ± 2*
Data from 13C NMR: fluxes relative to citrate synthase flux
PEPCK 5.9 ± 0.6 6.5 ± 0.4 4.5 ± 0.2* 4.3 ± 0.4* 2.00 ± 0.3*
Pyruvate cycling (PK+ME) 2.1 ± 0.4 2.7 ± 0.2 1.5 ± 0.2 1.4 ± 0.1* 0.16 ± 0.04*
Gluconeogenesis from PEP 3.8 ± 0.3 3.8 ± 0.2 3.0 ± 0.01* 2.9 ± 0.3* 1.86 ± 0.3*
n = 5 7 5 5 5
Livers from fasted mice were perfused with nonrecirculating media. Data are presented as mean ± SEM. *p < 0.05 versus control
(pcklox/lox); #p < 0.05 versus column to the left. bd, below detection limits.upon inhibition of hepatocyte glucose production from
lactate in the presence of the PEPCK inhibitor mercapto-
picolinate. This conclusion was later disputed by Groen
et al. (1982) and others, who used both inhibitor methods
and elasticities to show that PEPCK was only weakly con-
trolling in isolated hepatocytes (Argaud et al., 1991; Groen
et al., 1986; Rigoulet et al., 1987). These groups con-
cluded that, depending on hormone exposure, pyruvate
carboxylase and/or pyruvate kinase were more important
enzymes in controlling the rate of gluconeogenesis (Groen
et al., 1986). More recently, similar results were obtained
by a combination of GC/MS-based metabolomic and
mass isotopomer analysis in perfused rat liver treated
with mercaptopicolinate (Yang et al., 2006).
When PEPCK flux was measured as a function of
PEPCK protein content in the intact isolated mouse liver,
the results suggested only a weak relationship between316 Cell Metabolism 5, 313–320, April 2007 ª2007 Elsevier InPEPCK protein content and flux through the enzyme.
One important consideration is whether gradations in
PEPCK protein levels in the present study are representa-
tive of typical physiological levels in response to hormone-
mediated PEPCK expression. Presumably, PEPCK pro-
tein content in 24 hr-fasted control mice represents the
highest normal hepatic PEPCK content. The 90% reduc-
tion of PEPCK found in the pcklox + neo/del mouse is sub-
stantially more dramatic than the 50% reduction found af-
ter hyperinsulinemic clamp in mice (Sun et al., 2002), yet
hyperinsulinemic clamp dramatically suppresses gluco-
neogenesis, while PEPCK deficiency alone only de-
creases it by 40%. This suggests that other factors such
as peripheral substrate supply or insulin-mediated effects
on other gluconeogenic enzymes and/or hepatic energy
metabolism must coordinate with PEPCK expression to
attenuate gluconeogenesis.Table 2. Glucose Production, Oxygen Consumption, and Absolute Fluxes
Strain pcklox/lox pckdel/W pcklox/neo pcklox + neo/del pcklox/lox + AlbCre
Substrate uptake and production (mmol/min/grams wet weight)
Glucose production 0.47 ± 0.10 0.35 ± 0.07 0.31 ± 0.06 0.35 ± 0.01* 0.20 ± 0.10*
O2 consumption 2.20 ± 0.17 2.40 ± 0.34 2.00 ± 0.31 1.90 ± 0.18 1.74 ± 0.24*
Flux of substrate to glucose (mmol/min/grams wet weight)
Glycogen (GLY) 0.02 ± 0.01 0.00 ± 0.01 0.03 ± 0.01 0.00 ± 0.03 0.01 ± 0.02
Glycerol (GNGglycerol) 0.47 ± 0.13 0.39 ± 0.09 0.23 ± 0.09 0.42 ± 0.02 0.35 ± 0.18
PEP (GNGPEP) 0.43 ± 0.12 0.31 ± 0.05 0.33 ± 0.05 0.28 ± 0.04 0.03 ± 0.02*
Fluxes associated with the TCA cycle (mmol/min/grams wet weight)
PEPCK 0.65 ± 0.15 0.54 ± 0.08 0.49 ± 0.04 0.41 ± 0.04 0.03 ± 0.02*
Pyruvate cycling (PK+ME) 0.22 ± 0.05 0.22 ± 0.03 0.16 ± 0.02* 0.13 ± 0.01 0.00 ± 0.08*
TCA cycle (citrate synthase) 0.12 ± 0.04 0.09 ± 0.02 0.11 ± 0.02 0.10 ± 0.01 0.02 ± 0.01*
Livers from fastedmicewere perfusedwith nonrecirculatingmedia. Absolute fluxeswere determined from theNMRdata and rate of
glucose production (see Supplemental Experimental Procedures). Data are presented as mean ± SEM.*p < 0.05 versus control
(pcklox/lox).c.
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NMR Analysis of PEPCK Control StrengthFigure 2. Influence of PEPCK Protein Content and TCA Cycle
Flux on PEPCK Flux in Isolated Livers
(A) PEPCK flux versus liver PEPCK protein content. The data indicate
that large changes in PEPCK content are required to modulate even
small changes in flux through PEPCK. Metabolic control analysis of
these data provided a control coefficient of 0.18, indicating that under
these conditions, PEPCK content is not rate limiting for gluconeo-
genesis.
(B) Plot of PEPCK flux versus TCA cycle flux (relative to the average of
pcklox/lox) for all 27 livers studied. There was a strong correlation (p <
0.001) between TCA cycle flux and PEPCK flux. These data directly
link energy produced in the hepatic TCA cycle to the energy-consum-
ing process of gluconeogenesis.
(C) Under the conditions studied here, hepatic PEPCK protein content
has only a weak influence on the rate of PEPCK flux and gluconeo-CIt remains unclear whether compensatory mechanisms
in hepatic metabolism due to chronic PEPCK deficiency
play a role in the apparent low control strength of PEPCK
over hepatic gluconeogenesis or whether PEPCK might
even have a different control strength in vivo. These ques-
tions linger mainly because the low control strength for
PEPCK over its own flux is difficult to rationalize in light
of the exquisite hormonal control of PEPCK expression
and the fact that several interventions of PEPCK expres-
sion have demonstrated remarkable effects on systemic
glucose metabolism in mice. A 7-fold overexpression of
PEPCK results in hyperglycemia (Valera et al., 1994), while
a 2-fold overexpression results in insulin resistance (Sun
et al., 2002). The complexity of transcriptional regulation
of gluconeogenesis was nicely illustrated in the latter
study, where a point mutation in PEPCK expression also
resulted in overexpression of glucose-6-phosphatase
and underexpression of glucokinase and GLUT2, all con-
ditions that naturally contribute to increased gluconeo-
genic flux. The opposite was illustrated by Perales and co-
workers (Gomez-Valades et al., 2006), who used PEPCK
RNA silencing to suppress PEPCK expression in diabetic
mice, resulting in correction of hyperglycemia. Interest-
ingly, they also noted that inhibiting PEPCK expression
in diabetic mice decreased circulating fatty acids and in-
creased circulating ketones, suggesting an interaction
between PEPCK expression and hepatic energy metabo-
lism. On the other hand, a variety of studies in mice dem-
onstrate important modulations in hepatic glucosemetab-
olism even in the absence of altered PEPCK expression
(Burgess et al., 2006; Kersten et al., 1999) or altered
PEPCK expression without significant effect on gluconeo-
genesis (Xu et al., 2006). This disconnection might occur
because other factors, such as hepatic energy metabo-
lism (Pryor et al., 1987), can also project substantial
control over the rate of gluconeogenesis. The present
data indicate that changes in PEPCK content alone may
be insufficient to modulate gluconeogenesis; thus, taken
in combination with prior knowledge regarding the exqui-
site regulation of this enzyme, it seems likely that PEPCK
expression must coordinate with other mechanisms to
regulate gluconeogenesis.
The finding that PEPCK flux is intimately linked to he-
patic energy metabolism as well as gluconeogenesis fits
with earlier observations that flux through PEPCK is nec-
essary for normal energy generation in the hepatic TCA
cycle (Burgess et al., 2004; Hakimi et al., 2005). In the
complete absence of hepatic PEPCK, livers accumulate
triglycerides (She et al., 2000) secondary to decreased
fat oxidation in the TCA cycle (Burgess et al., 2004; Hakimi
et al., 2005). Moreover, when hepatic TCA cycle activity is
limited by decreased TCA cycle and electron transport
chain enzyme expression, PEPCK flux and gluconeogen-
esis are also impaired (Burgess et al., 2006). Together,
genesis, while the rate of energy produced by the hepatic TCA cycle
is strongly correlated with the rate of hepatic PEPCK flux (and gluco-
neogenesis), providing a potential mechanism by which gluconeogen-
esis and the energy required for this process are coordinated.ell Metabolism 5, 313–320, April 2007 ª2007 Elsevier Inc. 317
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aplerosis and energy generated in the hepatic TCA cycle
(Figure 2C), a mechanism which may allow appropriate
coordination of energy production and anabolism, specif-
ically gluconeogenesis. This coordination may be facili-
tated by PC flux since this enzyme is under allosteric con-
trol by acetyl-CoA, whose levels are responsive to the
energy state of the hepatocyte via b-oxidation and oxida-
tion in the TCA cycle. The ostensibly separate pathways of
hepatic energy production and gluconeogenesis are in
fact linked transcriptionally by a number of coactivators,
such as PGC-1 (Lin et al., 2005), TORC (Koo et al.,
2005), and the forkhead family of transcription factors
(Wolfrum et al., 2004; Zhang et al., 2006), that act as ‘‘mas-
ter regulators’’ controlling the expression of multiple en-
zymes of gluconeogenesis and fatty acid oxidation in par-
allel. In this way, the liver is well equipped to coordinate
the energy-consuming pathway of gluconeogenesis with
the energy-producing pathway of fat oxidation. Results
presented here suggest that one mechanism by which
the metabolic fluxes of gluconeogenesis and fat oxidation
interact involves oxidative flux through the TCA cycle,
leading to stimulation of anaplerosis, cataplerotic flux
through PEPCK, and ultimately gluconeogenesis (Fig-
ure 2C).
In summary, contrary to the widely held view that
PEPCK is the primary control point for gluconeogenesis,
the present results show that hepatic PEPCK content
alone only weakly influences gluconeogenesis. In light of
the robust response of PEPCK expression to physiology,
these data suggest a broader role for PEPCK, perhaps
in integrating hepatic energy metabolism and gluconeo-
genesis. In agreement with this role, we observed that
PEPCK flux correlates strongly with energy generated in
the hepatic TCA cycle. We hypothesize that in mice, hor-
mone-regulated PEPCK expression is generally controlled
in parallel with hepatic energy production, and these two
factors cooperate (perhaps with other factors as well) to
determine the rate of gluconeogenesis. Finally, these find-
ings demonstrate that metabolic flux is subject to regula-
tion by the entire metabolic network and that changes in
the expression, content, or activity of individual enzymes
do not always predictably affect flux through the intact
pathway.
EXPERIMENTAL PROCEDURES
Chemicals
[U-13C3] propionate (99%) and
2H2O (99%)were purchased fromCam-
bridge Isotopes. Other common chemicals were purchased from
Sigma unless otherwise noted.
Animals
Liver-specific PEPCK-deficient (pckdel/W, pcklox/neo, pcklox + neo/del,
pcklox/lox + AlbCre) and control (pcklox/lox) mice were generated as
previously described (She et al., 2000).
Liver Perfusion Experiments
All protocols were approved by the UTSWMC Institutional Animal Care
and Use Committee. Livers from various strains of mice were isolated
after a 24 hr fast and perfused without recirculation for 60 min as318 Cell Metabolism 5, 313–320, April 2007 ª2007 Elsevier Inpreviously detailed (Burgess et al., 2004, 2006; Hausler et al., 2006).
The perfusion media consisted of Krebs-Henseleit bicarbonate buffer
containing 1.5 mM lactate, 0.15 mM pyruvate, 0.25 mM glycerol, 0.2
mM octanoate, 0.5 mM [U-13C3]propionate, and 3% v/v D2O. Effluent
perfusate was collected for assays of glucose production and oxygen
consumption as well as isolation of glucose for NMR analysis as pre-
viously described (Burgess et al., 2004, 2006; Hausler et al., 2006).
Since there are no known allosteric activators of PEPCK (Hanson
and Patel, 1994), relative PEPCK protein content was taken as PEPCK
activity. Livers were freeze clamped after the perfusion period, and
PEPCK protein content was measured with standard western blotting
techniques. Tubulin protein content was used as an internal control
and was assumed to be unchanged in livers from various genotypes.
Tubulin monoclonal antibody was obtained from Sigma, and PEPCK
polyclonal antibody was obtained from Cayman Chemical. Four to
eight samples per strain were used to determine protein levels by com-
paring western blot densities. PEPCK and tubulin western blots were
run on the same gel, and relative PEPCK content was determined by
dividing the PEPCK density by the same sample’s tubulin density.
The PEPCK/tubulin ratio was set to 100% for the control strain
(pcklox/lox), and the other strains were normalized accordingly by divid-
ing their PEPCK/tubulin ratio by the control ratio. Relative PEPCK pro-
tein content is reported as a percent of control (mean ± SEM).
NMR Analysis
Glucose purified from the effluent perfusion media was converted to
the 1,2-diisopropylidene glucofuranose derivative (monoacetone glu-
cose, MAG) and analyzed by NMR at 14.1 T to determine the positional
enrichment of 2H and 13C as previously described (Burgess et al.,
2004, 2006; Hausler et al., 2006).
Metabolic Profile
Briefly (see also Supplemental Experimental Procedures), the relative
deuterium enrichments in glucose H2, H5, and H6s were determined
by 2H NMR, and these values were used to determine the rates of glu-
coneogenesis and glycogenolysis as previously described (Burgess
et al., 2003; Landau et al., 1995). Pathways intersecting the TCA cycle
were evaluated by 13C isotopomer analysis of glucose C2 (or gluta-
mate for PEPCK null livers). The 13C NMR multiplets in glucose or glu-
tamate generated by the tracer [U-13C3]propionate were evaluated to
determine flux through PEPCK and pyruvate cycling (Jones et al.,
1997). Fractional glycogenolysis and gluconeogenesis measured by
2H NMR were combined with PEPCK, pyruvate cycling and gluconeo-
genesis relative to TCA cycle flux measured by 13C NMR, and the ab-
solute rate of glucose production (mmol/min/g wet liver tissue) to yield
the absolute fluxes through each of these pathways (Burgess et al.,
2004).
Metabolic control analysis was performed as described by Fell
(1997). In brief, the natural log of relative PEPCK protein content was
plotted versus the natural log of PEPCK flux (for pckdel/W, pcklox/neo,
pcklox + neo/del, and pcklox/lox mice), and the slopewas taken as themet-
abolic control coefficient. This correlation gave a slope = 0.18 with
r = 0.94 (data not shown).
Statistical Methods
Statistical analyses were performed using SigmaStat 3.0 (SPSS, Inc.).
Differences between two groups were evaluated using unpaired t tests
(means) or Mann-Whitney rank-sum tests (medians). One-way ANOVA
or ANOVA based on ranks, followed bymultiple pairwise comparisons,
was used for multigroup comparisons. Correlations between variables
were determined using the Pearson product-moment test. p < 0.05
was considered statistically significant.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and Supplemental References and can be found with this article online
at http://www.cellmetabolism.org/cgi/content/full/5/4/313/DC1/.c.
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